MedPage Today on MSN4d
Updated CKD Guidelines Promote Cystatin C, Risk Equations, and SGLT2 InhibitorsUse of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...
Chronic Kidney Disease (CKD) indicates prolonged kidney damage over three months, often undetectable until significant harm ...
6 With regard to the gold-standard GFR method used by Schwartz and colleagues ... to identify the onset of renal insufficiency and end-stage renal disease and to errors in the prescribed dosage ...
March is National Kidney Month and WVU Medicine Barnesville Hospital wants to help you reduce your risk of developing chronic ...
They excluded patients with chronic kidney disease (CKD) stage 3 or higher. The early loss of renal function was defined as a loss in glomerular filtration rate (GFR) >3.3% per year. Of 355 ...
In February, the Clinical Kidney Journal published MediBeacon data in an article on Chronic Kidney Disease (CKD) stage misclassification via estimated GFR (eGFR) compared to measured GFR (mGFR ...
The TGFR, which includes Lumitrace (relmapirazin), was approved on January 17th by the U.S. Food and Drug Administration (FDA). MediBeacon continues development of future TGFR products including a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback